Formulations for the transdermal administration of fenoldopam
US6960353B2 · kind B2 · utility
3Cited by
64References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 29, 2003 |
| Grant date | Nov 1, 2005 |
| Priority date | — |
| Expiry date | Sep 29, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Composition of matter for application to skin to administer fenoldopam by permeation through the skin, the composition comprising fenoldopam to be administered, at a therapeutically effective rate, in combination with a permeation enhancer or mixture. Also disclosed are drug delivery devices and methods for the transdermal administration of fenoldopam for the treatment of hypertension, congestive heart failure, and chronic and acute renal failure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.